Discounted Cash Flow
Globus Medical Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $564.0m | $104.3m | $131.0m | 18.5% | $1.09 |
| 2017 | $636.0m (12.8%) | $107.3m (2.9%) | $108.2m (-17.4%) | 16.9% (-8.8%) | $1.12 (2.8%) |
| 2018 | $713.0m (12.1%) | $156.5m (45.8%) | $121.9m (12.7%) | 21.9% (30.0%) | $1.60 (42.9%) |
| 2019 | $785.4m (10.2%) | $155.2m (-0.8%) | $101.2m (-17.0%) | 19.8% (-10.0%) | $1.57 (-1.9%) |
| 2020 | $789.0m (0.5%) | $102.3m (-34.1%) | $135.1m (33.5%) | 13.0% (-34.4%) | $1.04 (-33.8%) |
| 2021 | $958.1m (21.4%) | $149.2m (45.9%) | $219.4m (62.3%) | 15.6% (20.1%) | $1.48 (42.3%) |
| 2022 | $1.0b (6.8%) | $190.2m (27.5%) | $104.4m (-52.4%) | 18.6% (19.4%) | $1.89 (27.7%) |
| 2023 | $1.6b (53.3%) | $122.9m (-35.4%) | $165.2m (58.2%) | 7.8% (-57.9%) | $1.09 (-42.3%) |
| 2024 | $2.5b (60.6%) | $103.0m (-16.2%) | $405.2m (145.2%) | 4.1% (-47.8%) | $0.76 (-30.3%) |
| 2025 | $2.9b (16.7%) | $537.9m (422.3%) | $588.8m (45.3%) | 18.3% (347.7%) | $3.98 (423.7%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.